In the case of non-small cell lung cancer (NSCLC) [56], FoxO1 phosphorylation facilitates cell proliferation and prevents apoptotic cell death, indicating that the nuclear barring of FoxO1 inhibits signaling pathways of programmed cell death. This evidence concerns the gene FOXO1 and non-small cell lung carcinoma.